COSM Marking Huge Growth and Buying Back Shares
Cosmos Health Expands Pharma Cell Partnership in Albania with Annualized Orders Projected to Exceed 54,000 Units
Cosmos Health Expands Partnership With Pharma Cell For Distribution Of Sky Premium Life Brand In Albania
Cosmos Health Share Buyback Expands to 5.11 Million Shares; Continues Open Market Repurchases
Cosmos Health Share Buyback Surpasses $1 Million, Reaching 4.84 Million Shares; Continues Open Market Repurchases
Cosmos Health Share Buyback Surpasses 4.5 Million Shares; Continues Open Market Repurchases
Cosmos Health Share Buyback Expands to 4.49 Million Shares; Continues Open Market Repurchases
Cosmos Health Share Buyback Reaches 4.36 Million Shares; Continues Open Market Repurchases
Cosmos Health Repurchases Additional 215K Shares At Average Price Of ~$0.325 Per Share
Cosmos Health Launches Subscription Model
Cosmos Health Rolls Out Subscription-Based Purchasing Model For Its Proprietary Client Health Brands
Cosmos Health Expands Share Buyback to 4.14 Million Shares; Continues Open Market Repurchases
Cosmos Health Share Buyback Surpasses 4 Million Shares; Continues Open Market Repurchases
Cosmos Health Share Buyback Expands to 3.87 Million Shares; Continues Open Market Repurchases
Cosmos Health Repurchases Additional 230K Shares At Average Price Of ~$0.2539/Share As Part Of Its Previously Announced Repurchase Program
Cosmos Health Reports Preliminary Record Q2 and H1 2026 Revenue, Up Over 30% Year-Over-Year; Continues Open Market Share Repurchases
Cosmos Health Reports Preliminary Q2 Revenue Of $19.4M, Up 31.5% YoY, H1 Revenue Of $37.3M, Up ~31% YoY
Cosmos Health Share Buyback Increases to 3.64 Million Shares; Continues Open Market Purchases
Cosmos Health Repurchases Additional 220K Shares At Average Price Of ~$0.2229/Share As Part Of Its Previously Announced Repurchase Program
Cosmos Health Expands Buyback to 3.42 Million Shares With Additional 770,000-Share Repurchase; Continues Open Market Purchases
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.